Developer docs
API playgroundTry for free, no card

Search company profiles

Humabiologics

Full company profile

uuid00042vq

Namestring
Humabiologics
Legal namestring
Humabiologics, Inc.
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Humabiologics is a Phoenix-based regenerative medicine company founded in 2018 that produces and sells native human-derived biomaterials — including collagen types I, II, IV, and V, gelatin, elastin, universal extracellular matrix (ECM), and tissue- and organ-specific ECM coatings — for use in research, 3D bioprinting, organoid and organ-on-chip development, and drug testing. Products are sourced from AATB-accredited tissue banks and manufactured under an ISO 13485:2016-certified quality system in an FDA-registered, cGMP-compliant facility, with two USPTO patents granted in November 2024 covering proprietary collagen and gelatin production processes. The portfolio spans 59 SKUs organized under sub-brands such as HumaDerm, HumaDerMA, HumaMatrix, Huma OsteoGelatin/OsteoGelMA, HumaElastin, and HumaOrganoMatrix.

The company sells primarily through a direct-to-researcher e-commerce storefront priced at unit levels ($95–$485 per SKU), complemented by a global distributor network covering tier-1 life science suppliers (Fisher Scientific, VWR, Millipore Sigma) in North America and dedicated regional partners across Europe (Ourobionics, Regemat 3D, Brinter, URMAT Biomedical) and Asia (Funakoshi, BestoBio, NO.1 Smart Technology, GrandBio, FoliBio). Named end-customers include major pharmaceutical firms (Novo Nordisk, Roche), academic centers (Yale, Rice, Ohio State, Scripps), and contract research organizations (Charles River Laboratories, Lonza), serving a horizontally diversified customer base across regenerative medicine, pharma/biotech, and CRO segments.

Cumulatively, Humabiologics has disclosed approximately $6.5M in funding ($1M seed in 2020, up to $3M exempt offering in 2022, and a $2.5M NSF grant in January 2025) and in November 2025 expanded operations to Winston-Salem, North Carolina's Innovation Quarter to develop and manufacture finished medical devices from native human collagen in collaboration with the Wake Forest Institute for Regenerative Medicine — a strategic pivot from a pure biomaterial supplier toward vertically integrated device development.

Short descriptiontext

Humabiologics produces and sells native human-derived collagen, gelatin, and extracellular matrix biomaterials — sourced from AATB-accredited tissue banks under ISO 13485 cGMP standards — to academic researchers, pharmaceutical companies, and CROs in regenerative medicine, 3D bioprinting, and drug testing applications globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPhoenix, United States
HQ citystring
Phoenix
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
human-derived biomaterials, regenerative medicine supplies, native human collagen, extracellular matrix products, 3D bioprinting bioinks
Industry2 codes
PRIMARYHLAAAGAF
Acellular/Decellularized Matrices & ECM Products
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAC
3D Bioprinting & Biofabrication
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Medical Equipment and Supplies Manufacturing3391
SIC code3 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Surgical & Medical Instruments & Apparatus3841
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Regenerative Medicine Biomaterials
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Biomaterial product sales
TypeOne Time License
Description

Direct sales of human-derived collagen and ECM products to researchers, with products sold at unit prices. One-time purchase model for research products.

humabiologics.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels12 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Standard per-unit pricing for all products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Research-grade human collagen: $350 (10mg), $485 (50mg). ECM coatings: $95 (tissue-specific), $135 (organ-specific). GelMA (Methacrylated collagen): $425 (10g). Lyophilized collagen options available at various concentrations.

humabiologics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1HumaDerm
Description

Human skin collagen type I products - solution, lyophilized, and insoluble forms for cell culture and 3D hydrogel applications

humabiologics.com
+8 more records
Core offering1 text field

Humabiologics manufactures and sells native human-derived biomaterials — including collagen (Types I, II, IV, V), gelatin, elastin, and tissue- and organ-specific extracellular matrix (ECM) products — for regenerative medicine research. Products are produced from donated human tissues sourced from AATB-accredited tissue banks under ISO 13485 cGMP standards and sold as research reagents in solution, lyophilized, insoluble, methacrylated, and pre-coated cultureware formats. The portfolio supports applications such as 2D/3D cell culture, organoids, bioprinting, bioinks, disease modeling, organ-on-chip, and drug testing.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Humabiologics is a biotechnology company offering a comprehensive portfolio of native human-derived biomaterials for regenerative medicine research. The core product lines include: (1) HumaDerm collagen products spanning Type I, II, IV, and V collagens from human skin and birth tissue, available as solutions, lyophilized powders, and insoluble formats; (2) HumaDerMA methacrylated collagen for photocrosslinking applications; (3) Huma OsteoGelatin and Huma OsteoGelMA gelatin products for bioink and 3D bioprinting; (4) HumaMatrix universal ECM in multiple formulations; (5) Tissue-specific ECM coatings (BoneMatrix, CartiMatrix, TenoMatrix, MyoMatrix, DermiMatrix, AdipoMatrix); (6) Organ-specific ECM coatings (HepatoMatrix, PneumoMatrix, CardioMatrix, NephroMatrix, PancreoMatrix); (7) HumaElastin matrix protein; and (8) Pre-coated cultureware products. The portfolio is designed to enable research applications including regenerative medicine, organoids, drug testing, 2D/3D cell culture, disease modeling, organ-on-a-chip, bioprinting, and bioinks. Products are GMP-compliant, ISO 13485 certified, and sourced exclusively from AATB-accredited tissue banks.

Product and service10 records
1HumaDerm Collagen Type I (Solution)
CategoryHuman Collagen Reagents
Description

Native human skin collagen type I solution at 3 mg/ml, 6 mg/ml, and 10 mg/ml concentrations used by researchers for cell culture and 3D hydrogel applications.

2HumaDerm Collagen Type I (Lyophilized)
CategoryHuman Collagen Reagents
Description

Freeze-dried native human skin collagen type I in 25 mg, 50 mg, and 100 mg sizes for coating tissue culture surfaces or preparing hydrogels in research workflows.

3HumaDerm Insoluble Collagen Type I
CategoryHuman Collagen Reagents
Description

Insoluble native human skin collagen type I, lyophilized, designed for tissue engineering scaffold preparation.

4HumaDerMA Methacrylated Collagen Type I
CategoryPhotocrosslinkable Bioinks
Description

Methacrylated human skin collagen type I that can be photocrosslinked for tunable 3D gel applications including 3D bioprinting and tissue engineering research.

5HumaDerm Coated Cultureware
CategoryCoated Cultureware
Description

Pre-coated tissue culture plates, flasks, and dishes with human skin collagen type I supplied ready-to-use for cell attachment and growth applications.

6HumaDerm Collagen Type II
CategoryHuman Collagen Reagents
Description

Native human cartilage collagen type II solution at 1 mg/ml targeted at cartilage research and joint-related applications.

7HumaDerm Collagen Type IV
CategoryHuman Collagen Reagents
Description

Native human birth tissue-derived collagen type IV, lyophilized, intended for basement membrane research.

8HumaDerm Collagen Type V
CategoryHuman Collagen Reagents
Description

Native human birth tissue-derived collagen type V solution for connective tissue research.

9Huma OsteoGelatin
CategoryHuman Gelatin Reagents
Description

Native human-derived gelatin available in high bloom and medium bloom strengths for bioink development and tissue engineering applications.

10Huma OsteoGelMA
CategoryPhotocrosslinkable Bioinks
Description

Methacrylated human gelatin that can be photocrosslinked for 3D bioprinting and biofabrication research.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership for clinical collaboration and device innovation. WFIRM is a leading institution in regenerative medicine research, providing clinical expertise and research capabilities for product development and validation.

2Piedmont Triad Regenerative Medicine Engine (PTRME)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Grant partnership funded by NSF supporting regenerative medicine research and development initiatives in the Piedmont Triad region of North Carolina.

humabiologics.com
3Allegro 3D
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership focused on human bioinks for 3D bioprinting applications, combining Humabiologics' human-derived materials with Allegro 3D's bioprinting technology.

humabiologics.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership for expanded market reach and potential product integration in the regenerative medicine space.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

European distribution partner handling sales and distribution of Humabiologics human bioinks and biomaterials across European markets.

6Funakoshi
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Japan distribution partner responsible for sales and distribution of Humabiologics products in the Japanese market.

humabiologics.com
7BestoBio
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

China distribution partner handling sales and distribution of Humabiologics products in mainland China.

humabiologics.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Korea distribution partner for Humabiologics products in the South Korean market.

9GrandBio
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Korea distribution partner serving the South Korean market alongside NO.1 Smart Technology.

humabiologics.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Taiwan distribution partner handling sales and distribution of Humabiologics products in Taiwan.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major US laboratory supplies distributor providing broad market access for Humabiologics products to research institutions and companies.

12VWR
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Laboratory supply distribution partner serving research customers across the United States.

13Millipore Sigma
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Laboratory supply distribution partner providing access to research customers through established distribution network.

humabiologics.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Spain distribution partner specializing in 3D bioprinting products and solutions for the Spanish market.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Finland distribution partner for 3D bioprinting and biomaterial products serving the Nordic market.

16URMAT Biomedical
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Slovenia distribution partner serving the Central European market for biomaterials and regenerative medicine products.

humabiologics.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Humabiologics

Regenerative Medicine Biomaterialshumabiologics.com

Humabiologics produces and sells native human-derived collagen, gelatin, and extracellular matrix biomaterials — sourced from AATB-accredited tissue banks under ISO 13485 cGMP standards — to academic researchers, pharmaceutical companies, and CROs in regenerative medicine, 3D bioprinting, and drug testing applications globally.

What Humabiologics does

Humabiologics is a Phoenix-based regenerative medicine company founded in 2018 that produces and sells native human-derived biomaterials — including collagen types I, II, IV, and V, gelatin, elastin, universal extracellular matrix (ECM), and tissue- and organ-specific ECM coatings — for use in research, 3D bioprinting, organoid and organ-on-chip development, and drug testing. Products are sourced from AATB-accredited tissue banks and manufactured under an ISO 13485:2016-certified quality system in an FDA-registered, cGMP-compliant facility, with two USPTO patents granted in November 2024 covering proprietary collagen and gelatin production processes. The portfolio spans 59 SKUs organized under sub-brands such as HumaDerm, HumaDerMA, HumaMatrix, Huma OsteoGelatin/OsteoGelMA, HumaElastin, and HumaOrganoMatrix.

The company sells primarily through a direct-to-researcher e-commerce storefront priced at unit levels ($95–$485 per SKU), complemented by a global distributor network covering tier-1 life science suppliers (Fisher Scientific, VWR, Millipore Sigma) in North America and dedicated regional partners across Europe (Ourobionics, Regemat 3D, Brinter, URMAT Biomedical) and Asia (Funakoshi, BestoBio, NO.1 Smart Technology, GrandBio, FoliBio). Named end-customers include major pharmaceutical firms (Novo Nordisk, Roche), academic centers (Yale, Rice, Ohio State, Scripps), and contract research organizations (Charles River Laboratories, Lonza), serving a horizontally diversified customer base across regenerative medicine, pharma/biotech, and CRO segments.

Cumulatively, Humabiologics has disclosed approximately $6.5M in funding ($1M seed in 2020, up to $3M exempt offering in 2022, and a $2.5M NSF grant in January 2025) and in November 2025 expanded operations to Winston-Salem, North Carolina's Innovation Quarter to develop and manufacture finished medical devices from native human collagen in collaboration with the Wake Forest Institute for Regenerative Medicine — a strategic pivot from a pure biomaterial supplier toward vertically integrated device development.

Humabiologics firmographics

Firmographics
Name
Humabiologics
Legal name
Humabiologics, Inc.
Website
https://humabiologics.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Humabiologics produces and sells native human-derived collagen, gelatin, and extracellular matrix biomaterials — sourced from AATB-accredited tissue banks under ISO 13485 cGMP standards — to academic researchers, pharmaceutical companies, and CROs in regenerative medicine, 3D bioprinting, and drug testing applications globally.
Ownership category
akta.pro rank

Humabiologics industry classification

Industry
Product category
Regenerative Medicine Biomaterials
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Medical Equipment and Supplies Manufacturing (3391)
SIC
Biological Products, (No Disgnostic Substances) (2836), Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAAAGAF
Acellular/Decellularized Matrices & ECM Products
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAAGAC
3D Bioprinting & Biofabrication
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

  • Human-derived biomaterials
  • Regenerative medicine supplies
  • Native human collagen
  • Extracellular matrix products
  • 3D bioprinting bioinks

Where Humabiologics is headquartered

Location

Headquarters

HQ city
Phoenix
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Humabiologics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Biomaterial product sales: Direct sales of human-derived collagen and ECM products to researchers, with products sold at unit prices. One-time purchase model for research products.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard per-unit pricing for all products

Go-to-market motion3 records

Distribution channels12 records

Marketing channels7 records

Humabiologics product offering

Product offering

Core offering

Humabiologics manufactures and sells native human-derived biomaterials — including collagen (Types I, II, IV, V), gelatin, elastin, and tissue- and organ-specific extracellular matrix (ECM) products — for regenerative medicine research. Products are produced from donated human tissues sourced from AATB-accredited tissue banks under ISO 13485 cGMP standards and sold as research reagents in solution, lyophilized, insoluble, methacrylated, and pre-coated cultureware formats. The portfolio supports applications such as 2D/3D cell culture, organoids, bioprinting, bioinks, disease modeling, organ-on-chip, and drug testing.

Product overview

Humabiologics is a biotechnology company offering a comprehensive portfolio of native human-derived biomaterials for regenerative medicine research. The core product lines include: (1) HumaDerm collagen products spanning Type I, II, IV, and V collagens from human skin and birth tissue, available as solutions, lyophilized powders, and insoluble formats; (2) HumaDerMA methacrylated collagen for photocrosslinking applications; (3) Huma OsteoGelatin and Huma OsteoGelMA gelatin products for bioink and 3D bioprinting; (4) HumaMatrix universal ECM in multiple formulations; (5) Tissue-specific ECM coatings (BoneMatrix, CartiMatrix, TenoMatrix, MyoMatrix, DermiMatrix, AdipoMatrix); (6) Organ-specific ECM coatings (HepatoMatrix, PneumoMatrix, CardioMatrix, NephroMatrix, PancreoMatrix); (7) HumaElastin matrix protein; and (8) Pre-coated cultureware products. The portfolio is designed to enable research applications including regenerative medicine, organoids, drug testing, 2D/3D cell culture, disease modeling, organ-on-a-chip, bioprinting, and bioinks. Products are GMP-compliant, ISO 13485 certified, and sourced exclusively from AATB-accredited tissue banks.

Differentiator

Problem solved

Functional benefit

Brands

  • HumaDerm: Human skin collagen type I products - solution, lyophilized, and insoluble forms for cell culture and 3D hydrogel applications
  • HumaMatrix
  • HumaDerMA
  • Huma OsteoGelatin
  • Huma OsteoGelMA
  • HumaElastin
  • HumaOrganoMatrix
  • HumaPneumoMatrix Coat
  • HumaHepatoMatrix Coat

Products and services

  • HumaDerm Collagen Type I (Solution) Native human skin collagen type I solution at 3 mg/ml, 6 mg/ml, and 10 mg/ml concentrations used by researchers for cell culture and 3D hydrogel applications.
  • HumaDerm Collagen Type I (Lyophilized) Freeze-dried native human skin collagen type I in 25 mg, 50 mg, and 100 mg sizes for coating tissue culture surfaces or preparing hydrogels in research workflows.
  • HumaDerm Insoluble Collagen Type I Insoluble native human skin collagen type I, lyophilized, designed for tissue engineering scaffold preparation.
  • HumaDerMA Methacrylated Collagen Type I Methacrylated human skin collagen type I that can be photocrosslinked for tunable 3D gel applications including 3D bioprinting and tissue engineering research.
  • HumaDerm Coated Cultureware Pre-coated tissue culture plates, flasks, and dishes with human skin collagen type I supplied ready-to-use for cell attachment and growth applications.
  • HumaDerm Collagen Type II Native human cartilage collagen type II solution at 1 mg/ml targeted at cartilage research and joint-related applications.
  • HumaDerm Collagen Type IV Native human birth tissue-derived collagen type IV, lyophilized, intended for basement membrane research.
  • HumaDerm Collagen Type V Native human birth tissue-derived collagen type V solution for connective tissue research.
  • Huma OsteoGelatin Native human-derived gelatin available in high bloom and medium bloom strengths for bioink development and tissue engineering applications.
  • Huma OsteoGelMA Methacrylated human gelatin that can be photocrosslinked for 3D bioprinting and biofabrication research.

Companies that use Humabiologics

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Humabiologics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Humabiologics partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core and minor.

  • Wake Forest Institute for Regenerative Medicine (WFIRM)coreStrategic or Co-development PartnerStrategic partnership for clinical collaboration and device innovation. WFIRM is a leading institution in regenerative medicine research, providing clinical expertise and research capabilities for product development and validation.
  • Piedmont Triad Regenerative Medicine Engine (PTRME)coreStrategic or Co-development PartnerGrant partnership funded by NSF supporting regenerative medicine research and development initiatives in the Piedmont Triad region of North Carolina.
  • Allegro 3DcoreStrategic or Co-development PartnerPartnership focused on human bioinks for 3D bioprinting applications, combining Humabiologics' human-derived materials with Allegro 3D's bioprinting technology.
  • PuredyneminorStrategic or Co-development PartnerStrategic partnership for expanded market reach and potential product integration in the regenerative medicine space.
  • OurobionicscoreChannel Partner/ Reseller/ DistributorEuropean distribution partner handling sales and distribution of Humabiologics human bioinks and biomaterials across European markets.
  • FunakoshicoreChannel Partner/ Reseller/ DistributorJapan distribution partner responsible for sales and distribution of Humabiologics products in the Japanese market.
  • BestoBiocoreChannel Partner/ Reseller/ DistributorChina distribution partner handling sales and distribution of Humabiologics products in mainland China.
  • NO.1 Smart TechnologyminorChannel Partner/ Reseller/ DistributorKorea distribution partner for Humabiologics products in the South Korean market.
  • GrandBiominorChannel Partner/ Reseller/ DistributorKorea distribution partner serving the South Korean market alongside NO.1 Smart Technology.
  • FoliBiominorChannel Partner/ Reseller/ DistributorTaiwan distribution partner handling sales and distribution of Humabiologics products in Taiwan.
  • Fisher ScientificcoreChannel Partner/ Reseller/ DistributorMajor US laboratory supplies distributor providing broad market access for Humabiologics products to research institutions and companies.
  • VWRcoreChannel Partner/ Reseller/ DistributorLaboratory supply distribution partner serving research customers across the United States.
  • Millipore SigmacoreChannel Partner/ Reseller/ DistributorLaboratory supply distribution partner providing access to research customers through established distribution network.
  • Regemat 3DminorChannel Partner/ Reseller/ DistributorSpain distribution partner specializing in 3D bioprinting products and solutions for the Spanish market.
  • BrinterminorChannel Partner/ Reseller/ DistributorFinland distribution partner for 3D bioprinting and biomaterial products serving the Nordic market.
  • URMAT BiomedicalminorChannel Partner/ Reseller/ DistributorSlovenia distribution partner serving the Central European market for biomaterials and regenerative medicine products.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Humabiologics competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Humabiologics social profiles

Digital presence

Humabiologics compliance and trust

Trust signal

Compliance3 records

Humabiologics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Humabiologics leadership team

Management profile

Number of profiles

Profiles2 records

Humabiologics funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Humabiologics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Humabiologics

What does Humabiologics do?

Humabiologics manufactures and sells native human-derived biomaterials — including collagen (Types I, II, IV, V), gelatin, elastin, and tissue- and organ-specific extracellular matrix (ECM) products — for regenerative medicine research. Products are produced from donated human tissues sourced from AATB-accredited tissue banks under ISO 13485 cGMP standards and sold as research reagents in solution, lyophilized, insoluble, methacrylated, and pre-coated cultureware formats. The portfolio supports applications such as 2D/3D cell culture, organoids, bioprinting, bioinks, disease modeling, organ-on-chip, and drug testing.

Is Humabiologics a public or private company?

Humabiologics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Humabiologics founded?

Humabiologics was founded in 2018. It employs 1 to 10 people.

Where is Humabiologics based?

Humabiologics is headquartered in Phoenix, United States, in the North America region.

How does Humabiologics make money?

One revenue line is on record: biomaterial product sales.

Does Humabiologics have an API?

No public API is recorded for Humabiologics.

What industry is Humabiologics in?

Humabiologics's product category is Regenerative Medicine Biomaterials. Its primary akta.pro industry code is HLAAAGAF, Acellular/Decellularized Matrices & ECM Products, with a secondary code of HLAAAGAC, 3D Bioprinting & Biofabrication. Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals